US Stock MarketDetailed Quotes
BNTC Benitec Biopharma
- 12.1700
- +0.3300+2.79%
Close Dec 19 16:00 ET
- 12.1700
- 0.00000.00%
Post 20:01 ET
282.54MMarket Cap-4.14P/E (TTM)
12.4400High11.6257Low72.18KVolume11.9000Open11.8400Pre Close871.58KTurnover0.56%Turnover RatioLossP/E (Static)23.22MShares13.290052wk High4.40P/B156.34MFloat Cap2.690052wk Low--Dividend TTM12.85MShs Float3939.6222Historical High--Div YieldTTM6.88%Amplitude1.8600Historical Low12.0750Avg Price1Lot Size
Benitec Biopharma Key Stats
Quarterly+Annual
YOY
| (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -0.20%-4.59M | -7.72%-19.4M | 19.58%-3.29M | -53.09%-6.17M | 8.18%-5.37M | -13.15%-4.58M | -13.29%-18.01M | 15.65%-4.1M | -17.74%-4.03M | -74.73%-5.84M |
| Net income from continuing operations | 15.03%-5.06M | -11.19%-21.75M | -1.27%-4.72M | 2.68%-4.28M | -25.63%-6.8M | -16.91%-5.95M | -7.44%-19.56M | 8.01%-4.66M | -34.30%-4.4M | -12.21%-5.41M |
| Depreciation and amortization | 10.98%91K | -9.97%343K | 8.33%91K | -3.23%90K | -21.57%80K | -19.61%82K | -2.81%381K | 33.33%84K | -18.42%93K | -9.73%102K |
| Change In working capital | -104.40%-53K | 64.43%1.17M | 147.75%882K | -1,185.50%-2.17M | 357.46%1.26M | 86.09%1.2M | -31.15%714K | 1,973.68%356K | 143.57%200K | -144.33%-489K |
| -Change in receivables | --226K | -252.00%-176K | ---176K | --0 | --0 | --0 | -5,100.00%-50K | --0 | --0 | ---- |
| -Change in prepaid assets | -85.90%100K | 255.80%645K | -1.50%-406K | 151.00%205K | -18.45%137K | 222.27%709K | -767.74%-414K | 26.87%-400K | ---402K | --168K |
| -Change in payables and accrued expense | -154.45%-306K | -31.47%980K | 87.07%1.53M | -446.92%-2.31M | 318.93%1.19M | 14.93%562K | 31.19%1.43M | 41.87%820K | 205.72%665K | -164.15%-544K |
| -Change in other current liabilities | -8.96%-73K | -9.13%-275K | -9.38%-70K | -9.52%-69K | -9.52%-69K | -8.06%-67K | -28.57%-252K | -14.29%-64K | -43.18%-63K | -43.18%-63K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -0.20%-4.59M | -7.72%-19.4M | 19.58%-3.29M | -53.09%-6.17M | 8.18%-5.37M | -13.15%-4.58M | -13.29%-18.01M | 15.65%-4.1M | -17.74%-4.03M | -74.73%-5.84M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -17,800.00%-179K | 0 | 92.31%-1K | -1K | ||||||
| Net PPE purchase and sale | ---- | -17,800.00%-179K | --0 | ---- | ---- | ---- | 92.31%-1K | ---1K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | -17,800.00%-179K | --0 | ---179K | --0 | --0 | 92.31%-1K | ---1K | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -22.44%21.66M | 324.78%68.03M | 40.07M | 0 | 39K | 74.33%27.92M | 16.02M | 0 | 0 | 0 |
| Net common stock issuance | -29.88%21.66M | 313.34%73.92M | --43M | --0 | --39K | 72.69%30.88M | --17.88M | --0 | --0 | --0 |
| Net other financing activities | ---- | -215.25%-5.89M | ---2.93M | --0 | --0 | -58.59%-2.96M | ---1.87M | --0 | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -22.44%21.66M | 324.78%68.03M | --40.07M | --0 | --39K | 74.33%27.92M | --16.02M | --0 | --0 | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 1,945.34%50.93M | -38.91%2.49M | 115.63%14.16M | 93.23%20.39M | 56.38%25.88M | -38.91%2.49M | -79.40%4.08M | -23.93%6.57M | -14.52%10.55M | 5.12%16.55M |
| Current changes in cash | -26.87%17.07M | 2,524.77%48.45M | 997.90%36.78M | -57.53%-6.35M | 8.85%-5.33M | 95.00%23.34M | 87.44%-2M | 15.86%-4.1M | -17.74%-4.03M | -74.73%-5.84M |
| Effect of exchange rate changes | -306.67%-93K | -101.94%-8K | -123.81%-5K | 167.44%115K | -6.54%-163K | -91.02%45K | 101.96%412K | -92.98%21K | 115.52%43K | -183.33%-153K |
| End cash Position | 162.41%67.91M | 1,945.34%50.93M | 1,945.34%50.93M | 115.63%14.16M | 93.23%20.39M | 56.38%25.88M | -38.91%2.49M | -38.91%2.49M | -23.93%6.57M | -14.52%10.55M |
| Free cash flow | -0.20%-4.59M | -8.71%-19.58M | 19.60%-3.29M | -57.53%-6.35M | 8.18%-5.37M | -13.15%-4.58M | -13.20%-18.01M | 15.86%-4.1M | -17.74%-4.03M | -74.73%-5.84M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data